OpenAlex
PricingAboutJobs
Log inGet started
Author

Jiahui Sun

Institution: Xuzhou Medical College
Observed institution: Xuzhou Medical College
ORCID: 0009-0003-5254-048X
Observed ORCID: 0009-0003-5254-048X
OpenAlex ID: A5140541190
Data from Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026 · Xiangmin Wang, Qing Zhang, et al.
Supplementary Data 1 from Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026 · Xiangmin Wang, Qing Zhang, et al.
Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026 · Xiangmin Wang, Qing Zhang, et al. · Clinical Cancer Research
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial
2026 · Affiliated Hospital of Xuzhou Medical University, Xiangmin Wang, et al. · Vivli
Works count: 4
Citation count:
H-index:
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security